Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 224 entries
Sorted by: Best Match Show Resources per page
Video-assisted thoracoscopy the total mesoesophageal excision and systematic en bloc mediastinal lymph node dissection.

Journal of visualized surgery

Kang M, Huang S, Lin J, Chen S, Lin J, Han W.
PMID: 29399489
J Vis Surg. 2016 May 30;2:102. doi: 10.21037/jovs.2016.05.03. eCollection 2016.

A 59-year-old female presented with upper esophageal squamous cell carcinoma had swallowing disorders. We performed the total mesoesophageal excision (TME) and systematic en bloc mediastinal lymph node dissection via VATS. The surgery process was successful and the postoperative course...

Cite
Kang M, Huang S, Lin J, et al. Video-assisted thoracoscopy the total mesoesophageal excision and systematic en bloc mediastinal lymph node dissection. J Vis Surg. 2016;2:102doi: 10.21037/jovs.2016.05.03.
Kang, M., Huang, S., Lin, J., Chen, S., Lin, J., & Han, W. (2016). Video-assisted thoracoscopy the total mesoesophageal excision and systematic en bloc mediastinal lymph node dissection. Journal of visualized surgery, 2102. https://doi.org/10.21037/jovs.2016.05.03
Kang, Mingqiang, et al. "Video-assisted thoracoscopy the total mesoesophageal excision and systematic en bloc mediastinal lymph node dissection." Journal of visualized surgery vol. 2 (2016): 102. doi: https://doi.org/10.21037/jovs.2016.05.03
Kang M, Huang S, Lin J, Chen S, Lin J, Han W. Video-assisted thoracoscopy the total mesoesophageal excision and systematic en bloc mediastinal lymph node dissection. J Vis Surg. 2016 May 30;2:102. doi: 10.21037/jovs.2016.05.03. eCollection 2016. PMID: 29399489; PMCID: PMC5783243.
Copy Download .nbib Format: NLM
Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis.

Pharmaceutics

Berenguer D, Sosa L, Alcover M, Sessa M, Halbaut L, Guillén C, Fisa R, Calpena-Campmany AC, Riera C.
PMID: 31731660
Pharmaceutics. 2019 Nov 15;11(11). doi: 10.3390/pharmaceutics11110613.

Cutaneous leishmaniasis (CL) is treated with painful intralesional injections of meglumine antimoniate (MA). With the aim of developing an alternative topical treatment for CL, a gel-based formulation with 30% MA was prepared and its physicochemical properties, stability and rheological...

Cite
Berenguer D, Sosa L, Alcover M, et al. Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis. Pharmaceutics. 2019;11(11)doi: 10.3390/pharmaceutics11110613.
Berenguer, D., Sosa, L., Alcover, M., Sessa, M., Halbaut, L., Guillén, C., Fisa, R., Calpena-Campmany, A. C., & Riera, C. (2019). Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis. Pharmaceutics, 11(11), . https://doi.org/10.3390/pharmaceutics11110613
Berenguer, Diana, et al. "Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis." Pharmaceutics vol. 11,11 (2019). doi: https://doi.org/10.3390/pharmaceutics11110613
Berenguer D, Sosa L, Alcover M, Sessa M, Halbaut L, Guillén C, Fisa R, Calpena-Campmany AC, Riera C. Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis. Pharmaceutics. 2019 Nov 15;11(11). doi: 10.3390/pharmaceutics11110613. PMID: 31731660; PMCID: PMC6920791.
Copy Download .nbib Format: NLM
rCBV- and ADC-based Grading of Meningiomas With Glimpse Into Emerging Molecular Diagnostics.

Basic and clinical neuroscience

Rohilla S, Garg HK, Singh I, Yadav RK, Dhaulakhandi DB.
PMID: 30719256
Basic Clin Neurosci. 2018 Nov-Dec;9(6):417-428. doi: 10.32598/bcn.9.6.417. Epub 2018 Nov 01.

INTRODUCTION: This study was conducted to grade meningiomas based on relative Cerebral Blood Volume (rCBV) and Apparent Diffusion Coefficient (ADC) to help surgeons plan the approach and extent of operation as well as decide on the need of any...

Cite
Rohilla S, Garg HK, Singh I, et al. rCBV- and ADC-based Grading of Meningiomas With Glimpse Into Emerging Molecular Diagnostics. Basic Clin Neurosci. 2018;9(6):417-428doi: 10.32598/bcn.9.6.417.
Rohilla, S., Garg, H. K., Singh, I., Yadav, R. K., & Dhaulakhandi, D. B. (2018). rCBV- and ADC-based Grading of Meningiomas With Glimpse Into Emerging Molecular Diagnostics. Basic and clinical neuroscience, 9(6), 417-428. https://doi.org/10.32598/bcn.9.6.417
Rohilla, Seema, et al. "rCBV- and ADC-based Grading of Meningiomas With Glimpse Into Emerging Molecular Diagnostics." Basic and clinical neuroscience vol. 9,6 (2018): 417-428. doi: https://doi.org/10.32598/bcn.9.6.417
Rohilla S, Garg HK, Singh I, Yadav RK, Dhaulakhandi DB. rCBV- and ADC-based Grading of Meningiomas With Glimpse Into Emerging Molecular Diagnostics. Basic Clin Neurosci. 2018 Nov-Dec;9(6):417-428. doi: 10.32598/bcn.9.6.417. Epub 2018 Nov 01. PMID: 30719256; PMCID: PMC6359681.
Copy Download .nbib Format: NLM
Management Strategy of Meconium Ileus-Outcome Analysis.

Journal of Indian Association of Pediatric Surgeons

Singh AK, Pandey A, Rawat J, Singh S, Wakhlu A, Kureel SN.
PMID: 31105398
J Indian Assoc Pediatr Surg. 2019 Apr-Jun;24(2):120-123. doi: 10.4103/jiaps.JIAPS_41_18.

BACKGROUND: Meconium ileus (MI) is defined as an intestinal obstruction caused by the impaction of inspissated meconium in the terminal ileum. In this study, we have evaluated the nonoperative management of patients of simple MI without fluoroscopic support -an...

Cite
Singh AK, Pandey A, Rawat J, et al. Management Strategy of Meconium Ileus-Outcome Analysis. J Indian Assoc Pediatr Surg. 2019;24(2):120-123doi: 10.4103/jiaps.JIAPS_41_18.
Singh, A. K., Pandey, A., Rawat, J., Singh, S., Wakhlu, A., & Kureel, S. N. (2019). Management Strategy of Meconium Ileus-Outcome Analysis. Journal of Indian Association of Pediatric Surgeons, 24(2), 120-123. https://doi.org/10.4103/jiaps.JIAPS_41_18
Singh, Abhishek Kumar, et al. "Management Strategy of Meconium Ileus-Outcome Analysis." Journal of Indian Association of Pediatric Surgeons vol. 24,2 (2019): 120-123. doi: https://doi.org/10.4103/jiaps.JIAPS_41_18
Singh AK, Pandey A, Rawat J, Singh S, Wakhlu A, Kureel SN. Management Strategy of Meconium Ileus-Outcome Analysis. J Indian Assoc Pediatr Surg. 2019 Apr-Jun;24(2):120-123. doi: 10.4103/jiaps.JIAPS_41_18. PMID: 31105398; PMCID: PMC6417045.
Copy Download .nbib Format: NLM
Development and characterization of liposomal formulation of bortezomib.

International journal of pharmaceutics: X

Deshantri AK, Metselaar JM, Zagkou S, Storm G, Mandhane SN, Fens MHAM, Schiffelers RM.
PMID: 31517276
Int J Pharm X. 2019 Mar 23;1:100011. doi: 10.1016/j.ijpx.2019.100011. eCollection 2019 Dec.

Bortezomib is a proteasome inhibitor used for the treatment of multiple myeloma. The poor pharmacokinetic profile and off-target adverse effects provide a strong incentive to develop drug delivery systems for bortezomib. In the past, liposomal encapsulation has been proven...

Cite
Deshantri AK, Metselaar JM, Zagkou S, et al. Development and characterization of liposomal formulation of bortezomib. Int J Pharm X. 2019;1:100011doi: 10.1016/j.ijpx.2019.100011.
Deshantri, A. K., Metselaar, J. M., Zagkou, S., Storm, G., Mandhane, S. N., Fens, M. H. A. M., & Schiffelers, R. M. (2019). Development and characterization of liposomal formulation of bortezomib. International journal of pharmaceutics: X, 1100011. https://doi.org/10.1016/j.ijpx.2019.100011
Deshantri, Anil K, et al. "Development and characterization of liposomal formulation of bortezomib." International journal of pharmaceutics: X vol. 1 (2019): 100011. doi: https://doi.org/10.1016/j.ijpx.2019.100011
Deshantri AK, Metselaar JM, Zagkou S, Storm G, Mandhane SN, Fens MHAM, Schiffelers RM. Development and characterization of liposomal formulation of bortezomib. Int J Pharm X. 2019 Mar 23;1:100011. doi: 10.1016/j.ijpx.2019.100011. eCollection 2019 Dec. PMID: 31517276; PMCID: PMC6733293.
Copy Download .nbib Format: NLM
Use of Diterpene Ginkgolides Meglumine Injection to Regulate Plasma Levels of PAI-1 and t-PA in Patients With Acute Atherosclerotic Cerebral Infarction.

The neurologist

Chen R, Yan L, Xie P, Tian J, Zhao Y, Liu Y, Xu J, Wang Y, Zhao L.
PMID: 34855657
Neurologist. 2021 Nov 30; doi: 10.1097/NRL.0000000000000399. Epub 2021 Nov 30.

BACKGROUND: To: (i) explore the effect of diterpene ginkgolides meglumine injection (DGMI) on neurological deficit symptoms in acute atherosclerotic cerebral infarction (AACI) patients; (ii) measure the level of plasma plasminogen activator inhibitor (PAI)-1 and tissue plasminogen activator (t-PA).METHODS: Eighty...

Cite
Chen R, Yan L, Xie P, et al. Use of Diterpene Ginkgolides Meglumine Injection to Regulate Plasma Levels of PAI-1 and t-PA in Patients With Acute Atherosclerotic Cerebral Infarction. Neurologist. 2021;doi: 10.1097/NRL.0000000000000399.
Chen, R., Yan, L., Xie, P., Tian, J., Zhao, Y., Liu, Y., Xu, J., Wang, Y., & Zhao, L. (2021). Use of Diterpene Ginkgolides Meglumine Injection to Regulate Plasma Levels of PAI-1 and t-PA in Patients With Acute Atherosclerotic Cerebral Infarction. The neurologist, . https://doi.org/10.1097/NRL.0000000000000399
Chen, Rui, et al. "Use of Diterpene Ginkgolides Meglumine Injection to Regulate Plasma Levels of PAI-1 and t-PA in Patients With Acute Atherosclerotic Cerebral Infarction." The neurologist vol. (2021). doi: https://doi.org/10.1097/NRL.0000000000000399
Chen R, Yan L, Xie P, Tian J, Zhao Y, Liu Y, Xu J, Wang Y, Zhao L. Use of Diterpene Ginkgolides Meglumine Injection to Regulate Plasma Levels of PAI-1 and t-PA in Patients With Acute Atherosclerotic Cerebral Infarction. Neurologist. 2021 Nov 30; doi: 10.1097/NRL.0000000000000399. Epub 2021 Nov 30. PMID: 34855657.
Copy Download .nbib Format: NLM
Meglumine Antimoniate-Loaded Aqueous-Core PLA Nanocapsules: Old Drug, New Formulation against Leishmania-Related Diseases.

Macromolecular bioscience

Cosco D, Bruno F, Castelli G, Puleio R, Bonacci S, Procopio A, Britti D, Fresta M, Vitale F, Paolino D.
PMID: 34117834
Macromol Biosci. 2021 Jul;21(7):e2100046. doi: 10.1002/mabi.202100046. Epub 2021 Jun 12.

Leishmaniasis is a human and animal disease endemic in tropical and subtropical areas treated by means of pentavalent antimony as first-line approach. Unfortunately, the formulations available on the market are characterized by significant side effects and a total remission...

Cite
Cosco D, Bruno F, Castelli G, et al. Meglumine Antimoniate-Loaded Aqueous-Core PLA Nanocapsules: Old Drug, New Formulation against Leishmania-Related Diseases. Macromol Biosci. 2021;21(7):e2100046doi: 10.1002/mabi.202100046.
Cosco, D., Bruno, F., Castelli, G., Puleio, R., Bonacci, S., Procopio, A., Britti, D., Fresta, M., Vitale, F., & Paolino, D. (2021). Meglumine Antimoniate-Loaded Aqueous-Core PLA Nanocapsules: Old Drug, New Formulation against Leishmania-Related Diseases. Macromolecular bioscience, 21(7), e2100046. https://doi.org/10.1002/mabi.202100046
Cosco, Donato, et al. "Meglumine Antimoniate-Loaded Aqueous-Core PLA Nanocapsules: Old Drug, New Formulation against Leishmania-Related Diseases." Macromolecular bioscience vol. 21,7 (2021): e2100046. doi: https://doi.org/10.1002/mabi.202100046
Cosco D, Bruno F, Castelli G, Puleio R, Bonacci S, Procopio A, Britti D, Fresta M, Vitale F, Paolino D. Meglumine Antimoniate-Loaded Aqueous-Core PLA Nanocapsules: Old Drug, New Formulation against Leishmania-Related Diseases. Macromol Biosci. 2021 Jul;21(7):e2100046. doi: 10.1002/mabi.202100046. Epub 2021 Jun 12. PMID: 34117834.
Copy Download .nbib Format: NLM
Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis.

Molecular immunology

Cardoso JMO, Brito RCF, Mathias FAS, Reis LES, Vieira JFP, Ostolin TLVDP, Andrade HM, Ramos GS, Frézard F, Aguiar-Soares RDO, Roatt BM, Reis AB.
PMID: 34814056
Mol Immunol. 2021 Nov 20;141:70-78. doi: 10.1016/j.molimm.2021.11.011. Epub 2021 Nov 20.

This study compared the therapeutic potential of the chemotherapy using meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes (Nano Sb

Cite
Cardoso JMO, Brito RCF, Mathias FAS, et al. Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis. Mol Immunol. 2021;141:70-78doi: 10.1016/j.molimm.2021.11.011.
Cardoso, J. M. O., Brito, R. C. F., Mathias, F. A. S., Reis, L. E. S., Vieira, J. F. P., Ostolin, T. L. V. D. P., Andrade, H. M., Ramos, G. S., Frézard, F., Aguiar-Soares, R. D. O., Roatt, B. M., & Reis, A. B. (2021). Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis. Molecular immunology, 14170-78. https://doi.org/10.1016/j.molimm.2021.11.011
Cardoso, Jamille Mirelle de Oliveira, et al. "Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis." Molecular immunology vol. 141 (2021): 70-78. doi: https://doi.org/10.1016/j.molimm.2021.11.011
Cardoso JMO, Brito RCF, Mathias FAS, Reis LES, Vieira JFP, Ostolin TLVDP, Andrade HM, Ramos GS, Frézard F, Aguiar-Soares RDO, Roatt BM, Reis AB. Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis. Mol Immunol. 2021 Nov 20;141:70-78. doi: 10.1016/j.molimm.2021.11.011. Epub 2021 Nov 20. PMID: 34814056.
Copy Download .nbib Format: NLM
Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study.

Investigative radiology

Ammari S, Bône A, Balleyguier C, Moulton E, Chouzenoux É, Volk A, Menu Y, Bidault F, Nicolas F, Robert P, Rohé MM, Lassau N.
PMID: 34324463
Invest Radiol. 2022 Feb 01;57(2):99-107. doi: 10.1097/RLI.0000000000000811.

MATERIALS AND METHODS: This monocentric retrospective study leveraged 200 multiparametric brain MRIs acquired between November 2019 and February 2020 at Gustave Roussy Cancer Campus (Villejuif, France). A total of 145 patients were included: 107 formed the training sample (55...

Cite
Ammari S, Bône A, Balleyguier C, et al. Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study. Invest Radiol. 2022;57(2):99-107doi: 10.1097/RLI.0000000000000811.
Ammari, S., Bône, A., Balleyguier, C., Moulton, E., Chouzenoux, �. �., Volk, A., Menu, Y., Bidault, F., Nicolas, F., Robert, P., Rohé, M. M., & Lassau, N. (2022). Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study. Investigative radiology, 57(2), 99-107. https://doi.org/10.1097/RLI.0000000000000811
Ammari, Samy, et al. "Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study." Investigative radiology vol. 57,2 (2022): 99-107. doi: https://doi.org/10.1097/RLI.0000000000000811
Ammari S, Bône A, Balleyguier C, Moulton E, Chouzenoux É, Volk A, Menu Y, Bidault F, Nicolas F, Robert P, Rohé MM, Lassau N. Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study. Invest Radiol. 2022 Feb 01;57(2):99-107. doi: 10.1097/RLI.0000000000000811. PMID: 34324463.
Copy Download .nbib Format: NLM
Outbreak of Cutaneous Leishmaniasis among military personnel in French Guiana, 2020: Clinical, phylogenetic, individual and environmental aspects.

PLoS neglected tropical diseases

Henry K, Mayet A, Hernandez M, Frechard G, Blanc PA, Schmitt M, André N, Loreau JM, Ginouves M, Prévot G, Couppié P, Demar M, Blaizot R.
PMID: 34797836
PLoS Negl Trop Dis. 2021 Nov 19;15(11):e0009938. doi: 10.1371/journal.pntd.0009938. eCollection 2021 Nov.

BACKGROUND: Cutaneous Leishmaniasis (CL) is endemic in French Guiana but cases are usually sporadic. An outbreak signal was issued on May 15th 2020 with 15 suspected cases after a military training course in the rainforest. An outbreak investigation was...

Cite
Henry K, Mayet A, Hernandez M, et al. Outbreak of Cutaneous Leishmaniasis among military personnel in French Guiana, 2020: Clinical, phylogenetic, individual and environmental aspects. PLoS Negl Trop Dis. 2021;15(11):e0009938doi: 10.1371/journal.pntd.0009938.
Henry, K., Mayet, A., Hernandez, M., Frechard, G., Blanc, P. A., Schmitt, M., André, N., Loreau, J. M., Ginouves, M., Prévot, G., Couppié, P., Demar, M., & Blaizot, R. (2021). Outbreak of Cutaneous Leishmaniasis among military personnel in French Guiana, 2020: Clinical, phylogenetic, individual and environmental aspects. PLoS neglected tropical diseases, 15(11), e0009938. https://doi.org/10.1371/journal.pntd.0009938
Henry, Kim, et al. "Outbreak of Cutaneous Leishmaniasis among military personnel in French Guiana, 2020: Clinical, phylogenetic, individual and environmental aspects." PLoS neglected tropical diseases vol. 15,11 (2021): e0009938. doi: https://doi.org/10.1371/journal.pntd.0009938
Henry K, Mayet A, Hernandez M, Frechard G, Blanc PA, Schmitt M, André N, Loreau JM, Ginouves M, Prévot G, Couppié P, Demar M, Blaizot R. Outbreak of Cutaneous Leishmaniasis among military personnel in French Guiana, 2020: Clinical, phylogenetic, individual and environmental aspects. PLoS Negl Trop Dis. 2021 Nov 19;15(11):e0009938. doi: 10.1371/journal.pntd.0009938. eCollection 2021 Nov. PMID: 34797836; PMCID: PMC8641862.
Copy Download .nbib Format: NLM
Feasibility of micropollutants removal by solar-activated persulfate: Reactive oxygen species formation and influence on DBPs.

Water research

Tan C, Zhao H, Wang X, Yu H, Chong S, Xu Y, Du E, Chen M, Peng X, Su L.
PMID: 34952455
Water Res. 2021 Dec 19;210:117981. doi: 10.1016/j.watres.2021.117981. Epub 2021 Dec 19.

As a natural source of visible light and a type of renewable energy, solar energy is extensively used in the field of photochemistry. In this study, solar was employed to activate persulfate (PS) to degrade typical micropollutants. The removal...

Cite
Tan C, Zhao H, Wang X, et al. Feasibility of micropollutants removal by solar-activated persulfate: Reactive oxygen species formation and influence on DBPs. Water Res. 2021;210:117981doi: 10.1016/j.watres.2021.117981.
Tan, C., Zhao, H., Wang, X., Yu, H., Chong, S., Xu, Y., Du, E., Chen, M., Peng, X., & Su, L. (2021). Feasibility of micropollutants removal by solar-activated persulfate: Reactive oxygen species formation and influence on DBPs. Water research, 210117981. https://doi.org/10.1016/j.watres.2021.117981
Tan, Chaoqun, et al. "Feasibility of micropollutants removal by solar-activated persulfate: Reactive oxygen species formation and influence on DBPs." Water research vol. 210 (2021): 117981. doi: https://doi.org/10.1016/j.watres.2021.117981
Tan C, Zhao H, Wang X, Yu H, Chong S, Xu Y, Du E, Chen M, Peng X, Su L. Feasibility of micropollutants removal by solar-activated persulfate: Reactive oxygen species formation and influence on DBPs. Water Res. 2021 Dec 19;210:117981. doi: 10.1016/j.watres.2021.117981. Epub 2021 Dec 19. PMID: 34952455.
Copy Download .nbib Format: NLM
Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis.

Molecular immunology

Cardoso JMO, Brito RCF, Mathias FAS, Reis LES, Vieira JFP, Ostolin TLVDP, Andrade HM, Ramos GS, Frézard F, Aguiar-Soares RDO, Roatt BM, Reis AB.
PMID: 34814056
Mol Immunol. 2021 Nov 20;141:70-78. doi: 10.1016/j.molimm.2021.11.011. Epub 2021 Nov 20.

This study compared the therapeutic potential of the chemotherapy using meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes (Nano Sb

Cite
Cardoso JMO, Brito RCF, Mathias FAS, et al. Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis. Mol Immunol. 2021;141:70-78doi: 10.1016/j.molimm.2021.11.011.
Cardoso, J. M. O., Brito, R. C. F., Mathias, F. A. S., Reis, L. E. S., Vieira, J. F. P., Ostolin, T. L. V. D. P., Andrade, H. M., Ramos, G. S., Frézard, F., Aguiar-Soares, R. D. O., Roatt, B. M., & Reis, A. B. (2021). Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis. Molecular immunology, 14170-78. https://doi.org/10.1016/j.molimm.2021.11.011
Cardoso, Jamille Mirelle de Oliveira, et al. "Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis." Molecular immunology vol. 141 (2021): 70-78. doi: https://doi.org/10.1016/j.molimm.2021.11.011
Cardoso JMO, Brito RCF, Mathias FAS, Reis LES, Vieira JFP, Ostolin TLVDP, Andrade HM, Ramos GS, Frézard F, Aguiar-Soares RDO, Roatt BM, Reis AB. Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis. Mol Immunol. 2021 Nov 20;141:70-78. doi: 10.1016/j.molimm.2021.11.011. Epub 2021 Nov 20. PMID: 34814056.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 224 entries